Stock BGNE BEIGENE, LTD.
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Editorial Features BeiGene, Ltd.

Equities

BGNE

US07725L1026

Biotechnology & Medical Research

Market Closed - Nasdaq
Other stock markets
 01:30:00 20/09/2024 am IST 		5-day change 1st Jan Change
198.59 USD +0.66% Intraday chart for BeiGene, Ltd. +1.18% +10.11%
18/09 JMP Securities Initiates BeiGene at Outperform With $288 Price Target MT
17/09 BeiGene Receives Israeli Ministry of Health Approval for TEVIMBRA® for the Treatment of Oesophageal Squamous Cell Carcinoma After Prior Chemotherapy CI

MarketScreener Editorial Features

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Analyst recommendations: Eli Lilly, KLA, Kellogg, Epam Systems, BeiGene...Analyst recommendations: Eli Lilly, KLA, Kellogg, Epam Systems, BeiGene... August 05, 2022 at 03:44 pm IST
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BGNE Stock
  4. News BeiGene, Ltd.
  5. MarketScreener Editorial Features
United States

MarketScreener is also available in this country: United States.

Switch edition
Stay in the current country edition